In 2015, the European Medicines Agency (EMA) celebrated its 20th anniversary, coinciding with the 50 years of pharmaceutical regulation in the European Union (EU). In the EU, pharmaceuticals are legislated at the EU level, but the enforcement of this legislation is typically left to the Member States. Yet also in this area we can see a trend of verticalization. This development has resulted in too complex procedures, with potential negative effects on accountability.
Author: Sabrina Wirtz & Merijn Chamon
Sabrina Wirtz (left) is a lecturer and PhD researcher at Maastricht University.
Merijn Chamon (right) is a postdoctoral assistant at Ghent University.